Cancer Research Technology
Log in Register
Menu

Anti-Growth Differentiation Factor 9B [28A]

Info

Catalogue Number 153650
Applications ELISA WB
Antigen/Gene or Protein Targets Growth Differentiation Factor 9B
Synonyms Bone morphogenetic protein 15, BMP-15, Growth/differentiation factor 9B, GDF9B
Reactivity Human
Relevance BMP15, also known as GDF9B, plays a crucial role in the regulation of fertility. Clone 28A has been used to detect BMP15 expression and biosynthesis in various carcinoma progression studies.
Host Mouse
Immunogen Recognizes sequence SAEVTASSSKHSGPENNQC on the C-terminus of human GDF9B (BMP15)
Subclass IgG1
Molecular Weight (kDa) 55
Myeloma Used Sp2/0-Ag14
Notes Suggested dilutions for use

Western Blot 1:5000
Immunocytochemistry Assay-dependent
ELISA Assay-dependent
Immunoblot 1:10000

Research Areas: Endocrinology;Cancer;Fertility;Developmental Biology
Research Area Cancer, Developmental Biology

References

There are 6 reference entries for this reagent.

View All References

References: 6 entries

Bone morphogenetic protein 15 in the pro-mature complex form enhances bovine oocyte developmental competence.

Europe PMC ID: 25058588

Sudiman et al. 2014. PLoS One. 9(7):e103563. PMID: 25058588.

Al-Musawi et al. 2013. Endocrinology. 154(2):888-99. PMID: 23284103.

Species differences in the expression and activity of bone morphogenetic protein 15.

Europe PMC ID: 23284103

Pulkki et al. 2011. Mol Cell Endocrinol. 332(1-2):106-15. PMID: 20937357.

The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region.

Europe PMC ID: 20937357


Add a reference

References: 6 entries

Bone morphogenetic protein 15 in the pro-mature complex form enhances bovine oocyte developmental competence.

Sudiman et al. 2014. PLoS One. 9(7):e103563. PMID: 25058588.

Al-Musawi et al. 2013. Endocrinology. 154(2):888-99. PMID: 23284103.

Species differences in the expression and activity of bone morphogenetic protein 15.

Pulkki et al. 2011. Mol Cell Endocrinol. 332(1-2):106-15. PMID: 20937357.

The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor

Invented at